Dark

Check out our API

CUR
Curando Nordic AB
stock NASDAQ

Inactive

May 23, 2025

5.04USD-93.040%(-67.37)400

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 6, 2022

06:00AM EST Consolidated Uranium Inc. (the "Company", CUR or Consolidated Uranium) (TSXV: CUR) (OTCQB: CURUF) has been requested by OTC Markets Group Inc. (OTC Markets) to issue this statement about promotional activity concerning its common shares (the Common Shares). GlobeNewswire Inc

Dec 30, 2021

07:07AM EST Emerging Markets Report: A December to Remember GlobeNewswire Inc

Nov 1, 2021

09:59AM EDT IIROC Trading Resumption - CUR PR Newswire

Oct 29, 2021

01:36PM EDT IIROC Trading Halt - CUR PR Newswire

Oct 25, 2021

08:35AM EDT Uranium, Strategic and Precious Metals Investor Presentations Now Available for PR Newswire

Aug 10, 2021

07:07AM EDT Emerging Markets Report: Consolidating Power GlobeNewswire Inc

May 13, 2021

09:24AM EDT IIROC Trading Resumption - CUR PR Newswire

May 12, 2021

02:59PM EDT IIROC Trading Halt - CUR PR Newswire

Mar 19, 2021

01:15PM EDT NeuroRx, Inc. announced the first patient in its P2/3 study of inhaled ZYESAMI in the treatment of moderate and severe COVID-19 (AVICOVID-2) was dosed at the University of California Irvine. The trial will be conducted at 10-15 clinical sites in the US. GlobeNewswire Inc

Dec 17, 2020

07:47AM EST Seneca Biopharma, Inc. (SNCA) and privately-held company Leading BioSciences, Inc. or LBS, announced Thursday that they have entered into a definitive agreement under which a wholly owned subsidiary of Seneca will merge with LBS in an all-stock transaction. RTTNews

Sep 2, 2020

08:01AM EDT Letter from Seneca Biopharma's Executive Chairman PR Newswire

Share